Stockscreener 앱 받기
4.61
7.80%
-0.39
전일 마감가:
$5.00
열려 있는:
$4.85
하루 거래량:
368.27K
Relative Volume:
1.52
시가총액:
$54.34M
수익:
$52.29M
순이익/손실:
$-73.52M
주가수익비율:
-6.9848
EPS:
-0.66
순현금흐름:
$-100.45M
1주 성능:
-9.07%
1개월 성능:
+5.25%
6개월 성능:
-8.89%
1년 성능:
-56.05%
1일 변동 폭
$4.50
$4.9664
1주일 범위
$4.50
$5.14
52주 변동 폭
$3.61
$10.68
Precision Biosciences Inc Stock (DTIL) Company Profile
명칭
Precision Biosciences Inc
전화
919-314-5512
주소
302 EAST PETTIGREW STREET, DURHAM, NC
DTIL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DTIL
Precision Biosciences Inc
|
4.61 | 59.05M | 52.29M | -73.52M | -100.45M | -0.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Precision Biosciences Inc Stock (DTIL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2024-04-30 | 개시 | Guggenheim | Buy |
| 2022-06-17 | 개시 | BMO Capital Markets | Outperform |
| 2022-06-09 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2020-07-27 | 재개 | BTIG Research | Buy |
| 2020-04-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-03-05 | 개시 | Stifel | Buy |
| 2020-02-25 | 개시 | William Blair | Outperform |
| 2019-08-09 | 개시 | BTIG Research | Buy |
| 2019-07-16 | 개시 | H.C. Wainwright | Buy |
| 2019-04-22 | 개시 | Barclays | Overweight |
| 2019-04-22 | 개시 | Goldman | Buy |
| 2019-04-22 | 개시 | JP Morgan | Overweight |
| 2019-04-22 | 개시 | Jefferies | Buy |
모두보기
Precision Biosciences Inc 주식(DTIL)의 최신 뉴스
Smart tools for monitoring Precision BioSciences Inc.’s price actionChart Signals & Proven Capital Preservation Tips - Newser
Precision BioSciences presents data from hepatitis B gene editing trial By Investing.com - Investing.com Australia
Can Precision BioSciences Inc. hit a new high this monthGlobal Markets & Free High Return Stock Watch Alerts - Newser
Is Precision BioSciences Inc. stock poised for growthWeekly Gains Report & Reliable Volume Spike Trade Alerts - Newser
Precision BioSciences Presents Data from the Phase 1 ELIMINATE-B Trial - Contract Pharma
Will Precision BioSciences Inc. bounce back from current supportTreasury Yields & AI Powered Market Entry Strategies - Newser
Custom strategy builders for tracking Precision BioSciences Inc.July 2025 PostEarnings & High Return Trade Opportunity Guides - Newser
Precision BioSciences Presents Data from the Phase 1 ELIMINATE-B Trial of PBGENE-HBV at the 6th Inte - PharmiWeb.com
Precision BioSciences presents phase 1 PBGENE-HBV trial data at HBV Cure Symposium; targets chronic hepatitis B - MarketScreener
Precision BioSciences presents data from hepatitis B gene editing trial - Investing.com
Precision BioSciences Presents Data from the Phase 1 ELIMINATE-B Trial of PBGENE-HBV at the 6th International Coalition to Eliminate HBV Cure Symposium - Yahoo Finance
Statistical indicators supporting Precision BioSciences Inc.’s strengthJuly 2025 Chart Watch & Advanced Technical Analysis Signals - Newser
Risk adjusted return profile for Precision BioSciences Inc. analyzedJuly 2025 Decliners & Short-Term Trading Opportunity Alerts - Newser
Will Precision BioSciences Inc. price bounce be sustainableTrade Entry Report & Reliable Price Breakout Signals - Newser
Top chart patterns to watch in Precision BioSciences Inc.July 2025 Highlights & Reliable Breakout Forecasts - Newser
Will Precision BioSciences Inc. continue its uptrendEarnings Overview Report & Daily Profit Maximizing Trade Tips - Newser
What MACD and RSI say about Precision BioSciences Inc.2025 Biggest Moves & Real-Time Sentiment Analysis - Newser
Comparing Precision BioSciences Inc. in custom built stock radarsMarket Growth Review & Free AI Powered Buy and Sell Recommendations - Newser
Can Precision BioSciences Inc. rally from current levelsIndex Update & Reliable Price Breakout Alerts - Newser
Precision BioSciences Inc. stock daily chart insightsTrade Exit Summary & Low Risk High Win Rate Picks - Newser
What recovery options are there for Precision BioSciences Inc.Weekly Risk Report & AI Powered Trade Plan Recommendations - Newser
Tools to assess Precision BioSciences Inc.’s risk profileEarnings Trend Report & Daily Technical Forecast Reports - Newser
Detecting support and resistance levels for Precision BioSciences Inc.Dividend Hike & Smart Allocation Stock Reports - Newser
Precision BioSciences Announces U.S. Patent Covering PBGENE-HBV for Chronic Hepatitis B and Updates Program Status - BioSpace
Precision BioSciences secures US patent for hepatitis B gene editing therapy - Investing.com
Precision BioSciences announces U.S. patent covering PBGENE-HBV for Chronic Hepatitis B and updates program status - MarketScreener
Custom watchlist performance reports with Precision BioSciences Inc.IPO Watch & Risk Controlled Swing Alerts - Newser
Will Precision BioSciences Inc. announce a stock split2025 Performance Recap & Daily Entry Point Trade Alerts - خودرو بانک
Real time alert setup for Precision BioSciences Inc. performance2025 Market Overview & Fast Moving Stock Watchlists - Newser
What’s the beta of Precision BioSciences Inc. stock2025 Key Lessons & Daily Price Action Insights - خودرو بانک
Using flow based indicators on Precision BioSciences Inc.2025 Big Picture & High Win Rate Trade Alerts - Newser
Layoff Tracker: AC Immune To Cut 30% of Workforce - BioSpace
Strategies to average down on Precision BioSciences Inc.July 2025 PreEarnings & AI Enhanced Trading Alerts - Newser
How to manage a losing position in Precision BioSciences Inc.July 2025 Selloffs & AI Driven Price Predictions - Newser
Published on: 2025-09-04 07:13:23 - Newser
Signal strength of Precision BioSciences Inc. stock in tech scannersMarket Volume Report & Growth Focused Investment Plans - Newser
Can Precision BioSciences Inc. recover in the next quarterJuly 2025 Spike Watch & Risk Controlled Daily Trade Plans - Newser
Precision BioSciences Inc.’s volatility index tracking explainedShort Setup & Real-Time Volume Analysis Alerts - Newser
How to use Fibonacci retracement on Precision BioSciences Inc.Jobs Report & Growth Oriented Trading Recommendations - Newser
Visual analytics tools that track Precision BioSciences Inc. performanceJuly 2025 Decliners & Reliable Volume Spike Trade Alerts - Newser
Precision BioSciences Updates Executive Employment Agreements - The Globe and Mail
Published on: 2025-09-03 01:30:24 - Newser
Precision Biosciences Inc (DTIL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
0.10%
자본화:
|
볼륨(24시간):